
MHRA approves stronger dosage of weight-loss medication
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new maximum weekly dose of semaglutide of up to 7.2mg. The regulatory agency shares that this is designed to target weight management in adults with obesity, and states that the higher dose applies only to patients with a body









